Search Results

There are 14154 results for: content related to: Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis

  1. You have free access to this content
    2017 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 69, Issue S10, October 2017, Pages: 1–4481,

    Version of Record online : 27 SEP 2017, DOI: 10.1002/art.40321

  2. Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2209–2217, Casper Steenholdt, Magid Al-khalaf, Jørn Brynskov, Klaus Bendtzen, Ole Ø. Thomsen and Mark A. Ainsworth

    Version of Record online : 16 FEB 2012, DOI: 10.1002/ibd.22910

  3. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  4. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  5. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  6. You have free access to this content
    Antitumor necrosis factor treatment for pediatric inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 5, May 2012, Pages: 985–1002, Charlotte I. de Bie, Johanna C. Escher and Lissy de Ridder

    Version of Record online : 20 SEP 2011, DOI: 10.1002/ibd.21871

  7. Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1628–1633, Uri Kopylov, Yoav Mazor, Miri Yavzori, Ella Fudim, Lior Katz, Daniel Coscas, Orit Picard, Yehuda Chowers, Rami Eliakim and Shomron Ben-Horin

    Version of Record online : 29 OCT 2011, DOI: 10.1002/ibd.21919

  8. You have free access to this content
    Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 4, August 2015, Pages: 391–405, J. P. Gisbert, A. C. Marín and M. Chaparro

    Version of Record online : 15 JUN 2015, DOI: 10.1111/apt.13276

  9. You have free access to this content
    Inflammatory Bowel Disease Clinical

    Journal of Gastroenterology and Hepatology

    Volume 32, Issue S2, August 2017, Pages: 121–154,

    Version of Record online : 17 AUG 2017, DOI: 10.1111/jgh.13895

  10. You have free access to this content
    Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 8, October 2012, Pages: 765–771, N. Vande Casteele, D. J. Buurman, M. G. G. Sturkenboom, J. H. Kleibeuker, S. Vermeire, T. Rispens, D. van der Kleij, A. Gils and G. Dijkstra

    Version of Record online : 28 AUG 2012, DOI: 10.1111/apt.12030

  11. You have free access to this content
    Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 12, June 2013, Pages: 1172–1183, C. Steenholdt, Y. Palarasah, K. Bendtzen, A. Teisner, J. Brynskov, B. Teisner and C. H. Nielsen

    Version of Record online : 7 MAY 2013, DOI: 10.1111/apt.12330

  12. You have free access to this content
    IBD Clinical

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue S2, October 2014, Pages: 102–123,

    Version of Record online : 13 OCT 2014, DOI: 10.1111/jgh.12736_6

  13. Monitoring functional serum antitumor necrosis factor antibody level in Crohn's disease patients who maintained and those who lost response to anti-TNF

    Inflammatory Bowel Diseases

    Volume 16, Issue 11, November 2010, Pages: 1898–1904, Akihiro Yamada, Koji Sono, Nobuo Hosoe, Nobuo Takada and Yasuo Suzuki

    Version of Record online : 22 MAR 2010, DOI: 10.1002/ibd.21259

  14. A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone

    British Journal of Dermatology

    Volume 172, Issue 3, March 2015, Pages: 760–768, R.P. Hall III, J. Fairley, D. Woodley, V.P. Werth, D. Hannah, R.D. Streilein, J. McKillip, J. Okawa, M. Rose, L.L. Keyes-Elstein, A. Pinckney, A. Overington, J. Wedgwood, L. Ding and B. Welch

    Version of Record online : 5 FEB 2015, DOI: 10.1111/bjd.13350

  15. Comparison of medical costs among patients using adalimumab and infliximab: A retrospective study (COMPAIRS)

    Inflammatory Bowel Diseases

    Volume 18, Issue 11, November 2012, Pages: 2043–2055, Daniel A. Sussman, Nisa Kubiliun, Parvez M. Mulani, Jingdong Chao, Carol A.T. Gillis, Mei Yang, Mei Lu and Maria T. Abreu

    Version of Record online : 12 JAN 2012, DOI: 10.1002/ibd.22873

  16. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 886–891, Shuji Yamamoto, Hiroshi Nakase, Minoru Matsuura, Yusuke Honzawa, Satohiro Masuda, Ken-ichi Inui and Tsutomu Chiba

    Version of Record online : 7 DEC 2009, DOI: 10.1111/j.1440-1746.2009.06206.x

  17. You have free access to this content
    Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 1, July 2011, Pages: 51–58, C. Steenholdt, M. Svenson, K. Bendtzen, O. Ø. Thomsen, J. Brynskov and M. A. Ainsworth

    Version of Record online : 3 MAY 2011, DOI: 10.1111/j.1365-2036.2011.04682.x

  18. Abstracts from the 2012 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference December 13–15, 2012 Hollywood, Florida

    Inflammatory Bowel Diseases

    Volume 18, Issue S1, December 2012, Pages: S1–S127,

    Version of Record online : 15 NOV 2012, DOI: 10.1002/ibd.23058

  19. Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: A 3-year prospective randomized open trial

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1617–1623, Koji Yoshida, Ken Fukunaga, Hiroki Ikeuchi, Koji Kamikozuru, Nobuyuki Hida, Yoshio Ohda, Yoko Yokoyama, Masaki Iimuro, Naohisa Takeda, Kyoichi Kato, Risa Kikuyama, Kazuko Nagase, Kazutoshi Hori, Shiro Nakamura, Hiroto Miwa and Takayuki Matsumoto

    Version of Record online : 13 NOV 2011, DOI: 10.1002/ibd.21928

  20. You have free access to this content
    Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 4, April 2010, Pages: 810–816, Daniel M Sinitsky, Daniel A Lemberg, Steven T Leach, Timothy D Bohane, Reuben Jackson and Andrew S Day

    Version of Record online : 24 NOV 2009, DOI: 10.1111/j.1440-1746.2009.06195.x